Pulmonary natural killer cell activity is reduced in patients with bronchogenic carcinoma

J. C. Weissler, L. P. Nicod, G. B. Toews

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Natural killer (NK) cells are a subpopulation of lymphocytes capable of killing a variety of tumor targets. They can limit pulmonary metastases in vivo and thus might be important effectors of tumor defense in human lung. Lymphocytes were purified from whole lung specimens obtained from patients with lung cancer undergoing curative resection, and their NK activity was compared with that of lymphocytes purified from normal lung specimens obtained undergoing medicolegal autopsy. The NK activity of pulmonary lymphocytes obtained from the patients with lung cancer was significantly lower (p < 0.05) than the NK activity of normal lungs. This reduction occurred despite high levels of blood NK activity in the patients with cancer, suggesting that NK cells might be locally suppressed in the lungs of patients with bronchogenic carcinoma. Because human pulmonary macrophages (PM) are known to be potent inhibitors of NK function, we investigated the role that PM might play in the reduction of NK activity in these patients. The PM obtained from the patients with lung cancer released soluble inhibitors of NK activity when stimulated with lipopolysaccharide. Release of these inhibitors was blocked by indomethacin, strongly suggesting a role for arachidonic acid metabolites as an inhibitor of pulmonary NK function. Inhibition of NK function by PM may occur in vivo, as a significant inverse correlation (r = -0.71. p < 0.001) existed between the NK activity of lymphocytes obtained from a lung and the number of PM present in the lung. Our results demonstrate a reduction in pulmonary NK activity in patients wtih bronchogenic carcinoma and suggest that local suppression of NK activity by PM may contribute to this finding.

Original languageEnglish (US)
Pages (from-to)1353-1357
Number of pages5
JournalAmerican Review of Respiratory Disease
Volume135
Issue number6
StatePublished - 1987

Fingerprint

Bronchogenic Carcinoma
Natural Killer Cells
Lung
Alveolar Macrophages
Lymphocytes
Lung Neoplasms
Neoplasms
Lymphocyte Subsets
Arachidonic Acid
Indomethacin
Lipopolysaccharides
Autopsy
Neoplasm Metastasis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Pulmonary natural killer cell activity is reduced in patients with bronchogenic carcinoma. / Weissler, J. C.; Nicod, L. P.; Toews, G. B.

In: American Review of Respiratory Disease, Vol. 135, No. 6, 1987, p. 1353-1357.

Research output: Contribution to journalArticle

@article{afb98a97a3d646ed96efe23f8993f0b4,
title = "Pulmonary natural killer cell activity is reduced in patients with bronchogenic carcinoma",
abstract = "Natural killer (NK) cells are a subpopulation of lymphocytes capable of killing a variety of tumor targets. They can limit pulmonary metastases in vivo and thus might be important effectors of tumor defense in human lung. Lymphocytes were purified from whole lung specimens obtained from patients with lung cancer undergoing curative resection, and their NK activity was compared with that of lymphocytes purified from normal lung specimens obtained undergoing medicolegal autopsy. The NK activity of pulmonary lymphocytes obtained from the patients with lung cancer was significantly lower (p < 0.05) than the NK activity of normal lungs. This reduction occurred despite high levels of blood NK activity in the patients with cancer, suggesting that NK cells might be locally suppressed in the lungs of patients with bronchogenic carcinoma. Because human pulmonary macrophages (PM) are known to be potent inhibitors of NK function, we investigated the role that PM might play in the reduction of NK activity in these patients. The PM obtained from the patients with lung cancer released soluble inhibitors of NK activity when stimulated with lipopolysaccharide. Release of these inhibitors was blocked by indomethacin, strongly suggesting a role for arachidonic acid metabolites as an inhibitor of pulmonary NK function. Inhibition of NK function by PM may occur in vivo, as a significant inverse correlation (r = -0.71. p < 0.001) existed between the NK activity of lymphocytes obtained from a lung and the number of PM present in the lung. Our results demonstrate a reduction in pulmonary NK activity in patients wtih bronchogenic carcinoma and suggest that local suppression of NK activity by PM may contribute to this finding.",
author = "Weissler, {J. C.} and Nicod, {L. P.} and Toews, {G. B.}",
year = "1987",
language = "English (US)",
volume = "135",
pages = "1353--1357",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "6",

}

TY - JOUR

T1 - Pulmonary natural killer cell activity is reduced in patients with bronchogenic carcinoma

AU - Weissler, J. C.

AU - Nicod, L. P.

AU - Toews, G. B.

PY - 1987

Y1 - 1987

N2 - Natural killer (NK) cells are a subpopulation of lymphocytes capable of killing a variety of tumor targets. They can limit pulmonary metastases in vivo and thus might be important effectors of tumor defense in human lung. Lymphocytes were purified from whole lung specimens obtained from patients with lung cancer undergoing curative resection, and their NK activity was compared with that of lymphocytes purified from normal lung specimens obtained undergoing medicolegal autopsy. The NK activity of pulmonary lymphocytes obtained from the patients with lung cancer was significantly lower (p < 0.05) than the NK activity of normal lungs. This reduction occurred despite high levels of blood NK activity in the patients with cancer, suggesting that NK cells might be locally suppressed in the lungs of patients with bronchogenic carcinoma. Because human pulmonary macrophages (PM) are known to be potent inhibitors of NK function, we investigated the role that PM might play in the reduction of NK activity in these patients. The PM obtained from the patients with lung cancer released soluble inhibitors of NK activity when stimulated with lipopolysaccharide. Release of these inhibitors was blocked by indomethacin, strongly suggesting a role for arachidonic acid metabolites as an inhibitor of pulmonary NK function. Inhibition of NK function by PM may occur in vivo, as a significant inverse correlation (r = -0.71. p < 0.001) existed between the NK activity of lymphocytes obtained from a lung and the number of PM present in the lung. Our results demonstrate a reduction in pulmonary NK activity in patients wtih bronchogenic carcinoma and suggest that local suppression of NK activity by PM may contribute to this finding.

AB - Natural killer (NK) cells are a subpopulation of lymphocytes capable of killing a variety of tumor targets. They can limit pulmonary metastases in vivo and thus might be important effectors of tumor defense in human lung. Lymphocytes were purified from whole lung specimens obtained from patients with lung cancer undergoing curative resection, and their NK activity was compared with that of lymphocytes purified from normal lung specimens obtained undergoing medicolegal autopsy. The NK activity of pulmonary lymphocytes obtained from the patients with lung cancer was significantly lower (p < 0.05) than the NK activity of normal lungs. This reduction occurred despite high levels of blood NK activity in the patients with cancer, suggesting that NK cells might be locally suppressed in the lungs of patients with bronchogenic carcinoma. Because human pulmonary macrophages (PM) are known to be potent inhibitors of NK function, we investigated the role that PM might play in the reduction of NK activity in these patients. The PM obtained from the patients with lung cancer released soluble inhibitors of NK activity when stimulated with lipopolysaccharide. Release of these inhibitors was blocked by indomethacin, strongly suggesting a role for arachidonic acid metabolites as an inhibitor of pulmonary NK function. Inhibition of NK function by PM may occur in vivo, as a significant inverse correlation (r = -0.71. p < 0.001) existed between the NK activity of lymphocytes obtained from a lung and the number of PM present in the lung. Our results demonstrate a reduction in pulmonary NK activity in patients wtih bronchogenic carcinoma and suggest that local suppression of NK activity by PM may contribute to this finding.

UR - http://www.scopus.com/inward/record.url?scp=0023622542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023622542&partnerID=8YFLogxK

M3 - Article

VL - 135

SP - 1353

EP - 1357

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 6

ER -